Influence of endothelin 1 receptor inhibition on functional, structural and molecular changes in the rat heart after irradiation

Radiation Research

Volumn 170, Issue 3, 2008, Pages 275-283

  Boerma, Marjan ^a   Wang, Junru ^a   Kulkarni, Ashwini ^a   Roberto, Kerrey A ^a   Qiu, Xiaohua ^a   Kennedy, Richard H ^b   Hauer Jensen, Martin ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; DRUG VEHICLE; ENDOTHELIN 1 RECEPTOR; ENDOTHELIN 1 RECEPTOR ANTAGONIST; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE FIBROSIS; HEART PERFUSION; ISOLATED HEART; MALE; MAST CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INDUCED HEART DISEASE; RAT; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY;

ANIMALS; CELLS, CULTURED; HEART; MALE; MAST CELLS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; SULFONAMIDES;

RATTUS;

EID: 51649111948     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1093.1     Document Type: Article

References (51)

1. M. J. Adams, P. H. Hardenbergh, L. S. Constine and S. E. Lipshultz, Radiation-associated cardiovascular disease. Crit. Rev. Oncol. He-matol, 45, 55-75 (2003).
2. S. C. Darby, P. McGale, C. W. Taylor and R. Peto, Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 6, 557-565 (2005).
3. P. A. Heidenreich, S. L. Hancock, R. H. Vagelos, B. K. Lee and I. Schnittger, Diastolic dysfunction after mediastinal irradiation. Am. Heart J. 150, 977-982 (2005).
4. M. J. Adams, S. R. Lipsitz, S. D. Colan, N. J. Tarbell, S. T. Treves, L. Diller, N. Greenbaum, P. Mauch and S. E. Lipshultz, Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J. Clin. Oncol. 22, 3139-3148 (2004).
5. M. J. Hooning, A. Botma, B. M. Aleman, M. H. Baaijens, H. Bar-telink, J. G. Klijn, C. W. Taylor and F. E. van Leeuwen, Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J. Natl. Cancer Inst. 99, 365-375 (2007).
6. M. Boerma, J. Wang, J. Wondergem, J. Joseph, X. Qiu, R. H. Kennedy and M. Hauer-Jensen, Influence of mast cells on structural and functional manifestations of radiation-induced heart disease. Cancer Res. 65, 3100-3107 (2005).
7. J. Joseph, R. H. Kennedy, S. Devi, J. Wang, L. Joseph and M. Hauer-Jensen. Protective role of mast cells in homocysteine-induced cardiac remodeling. Am. J. Physiol. Heart Circ. Physiol. 288, H2541-H2545 (2005).
8. M. Boerma, W P. Fiser, G. Hoyt, G J. Berry, L. Joseph, J. Joseph, J. Wang, M. D. Crew, R. C. Robbins and M. Hauer-Jensen, Influence of mast cells on outcome after heterotopic cardiac transplantation in rats. Transpl. Int. 20, 256-265 (2007).
9. J. Wang and M. Hauer-Jensen, Radiation toxicity and proteinase-activated receptors. Drug Dev. Res. 60, 1-8 (2003).
10. E. Crivellato, C. A. Beltrami. E Mallardi and D. Ribatti, The mast cell: an active participant or an innocent bystander? Histol. Histo-pathol. 19, 259-270 (2004).
11. T Siegal, M. R. Pfeffer, A. Meltzer, E. Shezen, A. Nimrod, N. Ezov and H. Ovadia, Cellular and secretory mechanisms related to delayed radiation-induced microvessel dysfunction in the spinal cord of rats. Int. J. Radiat. Oncol. Biol. Phys. 36, 649-659 (1996).
12. L. L. Yang, S. Arab, P. Liu, D. J. Stewart and M. Husain, The role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights. Can. J. Physiol. Pharmacol. 83, 47-62 (2005).
13. R. M. Kedzierski and M. Yanagisawa, Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41, 851-876 (2001).
14. D. Giannessi, R. S. Del and R. L. Vitale, The role of endothelins and their receptors in heart failure. Pharmacol. Res. 43, 111-126 (2001).
15. H. Ehrenreich, P. R. Burd, M. Rottem, L. Hultner, J. B. Hylton, M. Garfield, J. E. Coligan, D. D. Metcalfe and A. S. Fauci, Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New Biol. 4, 147-156 (1992).
16. M. Maurer, J. Wedemeyer, M. Metz, A. M. Piliponsky, K. Weller, D. Chatterjea, D. E. Clouthier, M. M. Yanagisawa, M. Tsai and S. J. Galli, Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432, 512-516 (2004).
17. K P. Metsarinne, P. Vehmaan-Rreula, P. T. Kovanen, O. Saijonmaa, M. Baumann, Y Wang, T Nyman, E Y Fyhrquist and K. K. Eklund, Activated mast cells increase the level of endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted Peptide. Arter-ioscler. Thromb. Vasc. Biol. 22, 268-273 (2002).
18. H. Yamamura. T. Nabe, S. Kohno and K. Ohata, Endothelin-1 induces release of histamine and leukotriene C4 from mouse bone marrow-derived mast cells. Eur. J. Pharmacol. 257, 235-242 (1994).
19. D. B. Murray, J. D. Gardner, G L. Brower and J. S. Janicki, Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am. J. Physiol. Heart Circ. Physiol. 287, H2295-H2299 (2004).
20. D. B. Murray, J. D. Gardner, G. L. Brower and J. S. Janicki, Effects of non-selective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats. Am. J. Physiol. Heart Circ. Physiol. 294, H1251-H1257 (2008).
21. S. Sakai, T. Miyauchi, T. Sakurai, Y. Kasuya, M. Ihara, I. Yamaguchi, K. Goto and Y Sugishita, Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart. Circulation 93, 1214-1222 (1996).
22. J. Piuhola, I. Szokodi, P. Kinnunen, M. Ilves, R. deChatel, O. Vuol-teenaho and H. Ruskoaho, Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts. Hypertension 41, 93-98 (2003).
23. T. Miyauchi and T. Masaki, Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 61, 391-415 (1999).
24. P. Cernacek, D. J. Stewart, J. C. Monge and J. L. Rouleau, The endothelin system and its role in acute myocardial infarction. Can. J. Physiol. Pharmacol. 81, 598-606 (2003).
25. G Ertl and J. Bauersachs, Endothelin receptor antagonists in heart failure: current status and future directions. Drugs 64, 1029-1040 (2004).
26. C. Parlapiano, V. Paoletti, E. Campana, T. Giovanniello, P. Pantone, G Labbadia, E Califano, L. Donnarumma and A. Musca, CGRP and ET-1 plasma levels in normal subjects. Eur. Rev. Med. Pharmacol. Sci. 3, 139-141 (1999).
27. Y Wang and D. H. Wang, Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP. Am. J. Physiol. Heart Circ. Physiol. 287, H1868-H1874 (2004).
28. Y J. Li and J. Peng, The cardioprotection of calcitonin gene-related peptide-mediated preconditioning. Eur. J. Pharmacol. 442, 173-177 (2002).
29. M. Katona, K. Boros. P. Santha, P. Ferdinandy, M. Dux and G Janc-so, Selective sensory denervation by capsaicin aggravates adriamy-cin-induced cardiomyopathy in rats. Naunyn Schmiedebergs Arch. Pharmacol. 370, 436-443 (2004).
30. M. Imamura, N. C. Smith, M. Garbarg and R. Levi, Histamine H3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop. Circ. Res. 78, 863-869 (1996).
31. M. Clozel, V. Breu, G A. Gray, B. Kalina, B. M. Loffler. K. Burri, J. M. Cassal, G. Hirth, M. Muller and H. Ramuz. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270, 228-235 (1994).
32. T Tsujimura, S. Hirota, S. Nomura, Y Niwa, M. Yamazaki, T Tono. E. Morii, H. M. Kim, K. Kondo and Y Kitamura, Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene. Blood 78, 1942-1946 (1991).
33. K. Horiguchi and T. Komuro, Ultrastructural characterization of interstitial cells of Cajal in the rat small intestine using control and WsJWs mutant rats. Cell Tissue Res. 293, 277-284 (1998).
34. J. Wondergem, A. van der Laarse, E J. Van Ravels, A. M. van Wer-meskerken, H. R. Verhoeve, B. W de Graaf and J. W. Leer, In vitro assessment of cardiac performance after irradiation using an isolated working rat heart preparation. Int. J. Radiat. Biol. 59, 1053-1068 (1991).
35. K. Fleckenstein, L. Zgonjanin, L. Chen, Z. Rabbani, I. L. Jackson, B. Thrasher, J. Kirkpatrick, W. M. Foster and Z. Vujaskovic, Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int. J. Radiat. Oncol. Biol. Phys. 68, 196-204 (2007).
36. R. Rola, Y Zou, T T Huang, K. Fishman, J. Baure. S. Rosi, H. Milliken, C. L. Limoli and J. R. Fike, Lack of extracellular superoxide dismutase (EC-SOD) in the microenvironment impacts radiation-induced changes in neurogenesis. Free Radic. Biol. Med. 42, 1133-1145 (2007).
37. S. Gilles. S. Zahler, U. Welsch, C. P. Sommerhoff and B. E Becker, Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc. Res. 60, 608-616 (2003).
38. K. Wolfreys and D. B. Oliveira, Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur. J. Immunol. 27, 297-306 (1997).
39. M. Hauer-Jensen. L. M. Fink and J. Wang, Radiation injury and the protein C pathway. Crit. Care Med. 32, S325-S330 (2004).
40. J. Wang, H. Zheng, C. C. Sung, K. K. Richter and M. Hauer-Jensen, Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy. Am. J. Pathol. 153, 1531-1540 (1998).
41. R. Takayanagi, K. Kitazumi, C. Takasaki, K. Ohnaka, S. Aimoto, K. Tasaka, M. Ohashi and H. Nawata, Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett. 282, 103-106 (1991).
42. M. Clozel, G A. Gray, V. Breu, B. M. Loffler and R. Osterwalder, The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem. Biophvs. Res. Commun. 186, 867-873 (1992).
43. E. Guarda, L. C. Katwa, P. R. Myers, S. C. Tyagi and K. T Weber, Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc. Res. 27, 2130-2134 (1993).
44. B. Hocher, I. George, J. Rebstock, A. Bauch, A. Schwarz, H. H. Neumayer and C. Bauer. Endothelin system-dependent cardiac remodeling in renovascular hypertension. Hypertension 33, 816-822 (1999).
45. S. Verma, E. Arikawa and J. H. McNeill, Long-term endothelin receptor blockade improves cardiovascular function in diabetes. Am. J. Hypertens. 14, 679-687 (2001).
46. K. K. Richter, C. W Langberg, C. C. Sung and M. Hauer-Jensen, Association of transforming growth factor beta (TGF-beta) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy. Radiother. Oncol 39, 243-251 (1996).
47. L. A. Sternberger and N. H. Sternberger, The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. J. Histochem. Cytochem. 34, 599-605 (1986).
48. M. Clozel and H. Salloukh, Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. Ann. Med. 37, 2-12 (2005).
49. P. Holm and A. Franco-Cereceda, Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo. Acta Physiol Scand. 165, 163-168 (1999).
50. P. Mulder. V. Richard, G Derumeaux, M. Hogie, J. P. Henry, E Lal-lemand, P. Compagnon, B. Mace, E. Comoy and C. Thuillez. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96, 1976-1982 (1997).
51. J. Wang, X. Qiu, A. Kulkarni and M. Hauer-Jensen, Calcitonin gene-related peptide and substance P regulate the intestinal radiation response. Clin. Cancer Res. 12, 4112-4118 (2006).